Quick Summary
Remestyp 1mg Injection
Last updated on 19 Aug 2026 | 06:50 AM (IST)
₹1762
MRP: ₹2002.5
(You Save ₹240.5)
1 VIAL(s)
Remestyp 1mg Injection
Salt Composition
TERLIPRESSINMarketer
FERRING PHARMACEUTICALS
Prepaid Only. Non-Returnable.
12% OFF
₹1762
MRP: ₹2,002.50
Inclusive of all taxes
12% Off
Salt Composition
TERLIPRESSINMarketer
FERRING PHARMACEUTICALS
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
T Press 1mg Injection
BHARAT SERUMS &...
₹ 133.00/injection
92% cheaper
Terliproof Injection 10ml
ARISTO PHARMACE...
₹ 637.00/injection
63% cheaper
Esoprezin 1mg Injection
SANFEGAN BIOTEC...
₹ 1388.00/injection
21% cheaper
Terlistat 1mg Injection
SAMARTH LIFE SC...
₹ 1838.00/injection
5% costlier


Introduction
Remestyp 1mg Injection contains an active ingredient called Terlipressin. It belongs to the medication class known as a vasopressin receptor agonist. It is used to treat bleeding from dilated veins in the food pipe that connects to the stomach, called bleeding oesophageal varices. It also improves kidney function in adults diagnosed with hepatorenal syndrome, a condition characterized by a sudden decline in kidney function.
Remestyp 1mg Injection should not be consumed if you are allergic to Terlipressin or any of its ingredients in the medication. Do not take this medicine if you have low oxygen levels (hypoxia), worsening respiratory symptoms, or reduced blood supply to the heart, limbs, or intestines. Before taking the medicine, inform your doctor if you have a severe infection known as septic shock, bronchial asthma or other respiratory conditions, uncontrolled high blood pressure, previous heart attack (myocardial infarction), hardening of the arteries (arteriosclerosis), irregular heartbeats (cardiac arrhythmias).
Notify your doctor if you have poor blood circulation to the brain (stroke), impaired kidney function (renal insufficiency), disturbances in the level of salt (electrolytes), reduced amount of fluid, or blood loss. Inform your doctor if you are pregnant, planning to get pregnant, breastfeeding, or being over the age of 70 years. Remestyp 1mg Injection is not recommended for children and adolescents. Inform your doctor if you are on a low-salt diet, as this medicine contains sodium. Remestyp 1mg Injection price varies by retailer and location.
Uses
Remestyp Injection uses are :
Treats bleeding esophageal varices.
Improve kidney function in adults with hepatorenal syndrome.
How Remestyp 1mg Injection Works
Remestyp 1mg Injection acts on the walls of blood vessels, leading to their constriction and reducing blood flow to the affected veins. This mechanism helps to stop or slow down the bleeding effectively.
Interaction of Remestyp 1mg Injection with other drugs
Domperidone (Life-threatening)
Using terlipressin with domperidone can severely disturb heart rhythm and increase the risk of dangerous arrhythmias. This combination should be strictly avoided.Artemether (Severe)
Artemether may further prolong the QT interval when taken with terlipressin, raising the chance of serious cardiac rhythm problems. Medical supervision is essential if both are required.Amiodarone (Severe)
Amiodarone can intensify terlipressin’s cardiac effects and increase arrhythmia risk. Doctors avoid using them together unless absolutely necessary.Other QT-Prolonging Antiarrhythmics (Moderate)
Medicines like sotalol, quinidine, or procainamide may add to terlipressin’s tendency to affect heart rhythm. Close cardiac monitoring is recommended if combined.Anesthetic Agents (Moderate)
Drugs used during anesthesia, especially those affecting blood pressure, may interact with terlipressin’s vasoconstrictive action. Monitoring during procedures is advised.
Storage
Keep out of sight and reach of pets and children.
Do not freeze the medicine.
Store in a refrigerator at 2-8˚C.
How to consume Remestyp 1mg Injection
Remestyp 1mg Injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered in a vein (intravenous). Your doctor will decide the Remestyp Injection dosage, route of administration, and frequency based on your disease condition and other factors.
Safety Advice
Pregnancy
Limited information is available on the use of Remestyp 1mg Injection during pregnancy. Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant.
Breast Feeding
It is unknown whether Remestyp 1mg Injection is excreted in breast milk. So, before starting the treatment, inform your doctor if you are breastfeeding. Contact your doctor for more information.
Lungs
It is unknown whether Remestyp 1mg Injection is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
Limited information is available on the use of Remestyp 1mg Injection in patients with liver conditions. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.
Alcohol
It is unknown whether consuming alcohol while taking Remestyp 1mg Injection is safe. Please speak with your physician.
Driving
It is unknown whether Remestyp 1mg Injection alters driving ability. However, if you experience side effects like tiredness or drowsiness, avoid driving and using machines.
Side effects
Remestyp Injection side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
Severe shortness of breath
Severe chest pain
Persistent and severe irregular heartbeats
Seizures
Kidney problems
Locally dead skin (necrosis)
Common
Diarrhea
Headache
High or low blood pressure
Abdominal cramps
Pale skin
Insufficient blood circulation in arms and legs
Slow heart rate
Expert Tips
Inform your doctor about all underlying medical conditions before starting Remestyp 1mg Injection.
Do not stop the medication unless your doctor advises.
Your doctor will monitor your heart and blood circulation regularly during treatment.
Do not double your dose to compensate for a missed dose.
Report any serious side effects promptly and follow your doctor’s guidance on dose adjustments.
FAQs
Q1.
What is Remestyp 1mg Injection?
Remestyp 1mg Injection is a medication used for various medical conditions, including managing acute variceal bleeding in the esophagus (food pipe) and treating hepatorenal syndrome, a kidney disorder associated with liver disease.
Q2.
How to manage the side effects of Remestyp 1mg Injection?
To manage the side effects of Remestyp 1mg Injection, follow the prescribed dosage, and report side effects promptly. Stay hydrated, and monitor your heart and blood circulation regularly. Adjustments in dosage, additional medications, or supportive care may be recommended to address the side effects effectively. Maintain a healthy lifestyle, and attend follow-up appointments.
Q3.
Can you take Remestyp 1mg Injection when pregnant?
Consult your medical professional regarding the use because only limited information on Remestyp 1mg Injection during pregnancy is available. The potential benefits and risks should be carefully assessed. Your doctor will suggest taking this medicine only if it's necessary.
Q4.
What are the side effects of Remestyp 1mg Injection?
Common side effects of Remestyp 1mg Injection include diarrhea, headache, high or low blood pressure, abdominal cramps, pale skin, insufficient blood circulation in arms and legs, and slow heart rate. It is crucial to consult your doctor for any concerns or persistent side effects.
Q5.
How to give Remestyp 1mg Injection?
Remestyp 1mg Injection is administered as an injection by a healthcare professional. It is typically given intravenously (IV). Do not self-administer.
Fact box
Molecule Name: | Terlipressin |
Therapeutic class: | Endogenous neurohormone |
Molecule Name: | Vasopressin receptor agonist |
Indications: | 1. Treats bleeding esophageal varices. 2. Improve kidney function in adults with hepatorenal syndrome. |
References
Flynn Pharma Ltd, Electronic Medicines Compendium (EMC), [Revised on May 2022] [Accessed on 28th June 2023], pil.9336.pdf (medicines.org.uk)
Mallinckrodt Pharmaceuticals, US Food and Drug Administration; [Revised on September 2023] [Accessed on 28th June 2023], label (fda.gov)
Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Regulation of renal function and vascular volume, 12th edition, 2011, 712.
KD Tripathi, Essentials of Medical Pharmacology, Antidiuretic drugs, 7th edition, 2013, 596.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr Arathy J S
BDS

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 19 Aug 2026 | 06:50 AM (IST)

Want to know more?
Read Our Editorial Policy







